Mounjaro and Zepbound are two brand names for tirzepatide injection: Mounjaro is labeled for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea.
- Mounjaro is for
- Type 2 diabetes in adults and children 10+, and heart-risk reduction in adults with type 2 diabetes [2]
- Zepbound is for
- Weight reduction in adults with obesity or overweight plus a condition, and sleep apnea with obesity [1]
- Use together?
- No. Zepbound should not be used with other tirzepatide products [5]
Quick answer
Yes, Mounjaro and Zepbound are the same drug. Both are tirzepatide injections from Eli Lilly, and both labels list single-dose pens or vials in 2.5, 5, 7.5, 10, 12.5 and 15 mg [1]. FDA approved Mounjaro for type 2 diabetes on May 13, 2022 [6] and Zepbound for chronic weight management on Nov 8, 2023 [7]. The brand you are prescribed depends mostly on your diagnosis, and that decides how insurance treats it.
Side-by-side
| Mounjaro | Zepbound | |
|---|---|---|
| Active ingredient | Tirzepatide [2] | Tirzepatide [1] |
| Approved uses | Blood sugar control in type 2 diabetes (adults and age 10+); lowering major heart events in high-risk adults with type 2 diabetes [2] | Weight reduction and maintenance in adults with obesity, or overweight with a related condition; moderate to severe sleep apnea with obesity [1] |
| Recent label changes | Pediatric use added 12/2025; heart-risk use added 08/2026 [2] | Sleep apnea added Dec 20, 2024 [8] |
| Starting dose | 2.5 mg weekly [2] | 2.5 mg weekly for 4 weeks [1] |
| Step-ups | 2.5 mg steps after at least 4 weeks if more blood sugar control is needed [2] | 5 mg after 4 weeks, then 2.5 mg steps after at least 4 weeks [1] |
| Maintenance and max | No separate maintenance list; max 15 mg adults, 10 mg children [2] | 5, 10 or 15 mg for weight; 10 or 15 mg for sleep apnea; max 15 mg [1] |
| Missed dose | Within 4 days, otherwise skip [2] | Within 4 days, otherwise skip [1] |
| Pregnancy wording | Use only if benefit justifies fetal risk [2] | Stop when pregnancy is recognized [9] |
| Price | List $1,112.16 per 28 days; savings card $25 if covered, $499 if not covered [3] [10] | LillyDirect $299 to $449; list $1,087 [4] [11] |
| Medicare | Regular Part D plans may cover it for type 2 diabetes [12] | KwikPen through the GLP-1 Bridge for $50 if eligible [12] |
Which is better for weight loss?
The molecule is identical, so the question is about the trials behind each label. Zepbound's weight trials reported an average loss of 15.0%, 19.5% and 20.9% at 5, 10 and 15 mg over 72 weeks in adults without diabetes, versus 3.1% on placebo [9]. In adults with type 2 diabetes, Zepbound's label reports 12.8% at 10 mg and 14.7% at 15 mg versus 3.2% [9]. Mounjaro's label is built around blood sugar, not weight [2].
Side effect rates also look different on paper. Nausea was 12% to 18% on Mounjaro in diabetes trials and 25% to 29% on Zepbound in weight trials [2] [9]. Those trials enrolled different people at different doses, so the gap does not mean one brand is gentler. See tirzepatide side effects and Mounjaro side effects.
Which is cheaper?
Without insurance, Zepbound is usually cheaper because Lilly sells it self-pay: $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg through LillyDirect if refilled within 45 days, checked Oct 17, 2026 [4]. Mounjaro's list price is $1,112.16 for four pens [3]. Lilly's Mounjaro savings card brings a covered prescription to as little as $25 (up to $150 off a month) or an uncovered one to as little as $499, but it requires commercial insurance and a prescription for an approved use [10]. We could not confirm a LillyDirect self-pay price for Mounjaro.
More on Mounjaro cost, Zepbound cost and insurance for Zepbound or Mounjaro.
How compounded tirzepatide differs from both
Compounded tirzepatide is made by a pharmacy, not by Lilly, and it is not FDA-approved; FDA does not review it for safety, effectiveness or quality [13]. FDA has told telehealth companies that calling a compounded drug "generic," saying it has the "same active ingredient" as a brand, or implying it matches a brand's results is misleading [14]. Some compounded products also contain added ingredients: FDA's Sept 18, 2026 letter to Empower Pharmacy cited tirzepatide with niacinamide [15]. FDA had more than 730 adverse event reports for compounded tirzepatide as of May 31, 2026 [13]. Read compounded tirzepatide.
Switching between Mounjaro and Zepbound
People switch brands when a diagnosis or coverage changes. Because both are tirzepatide, Lilly says Zepbound should not be used with other tirzepatide-containing products [5], and Zepbound's label adds that it is not recommended with any GLP-1 receptor agonist [1]. The labels do not give a brand-to-brand switching schedule; the strengths are the same, and your prescriber sets the dose. The label schedule is on Mounjaro dosage. See switching GLP-1s.
Who each fits
- Mounjaro fits a type 2 diabetes diagnosis, including the label's heart-risk use and children 10 and older [2]. Insurance and Medicare drug plans treat it as a diabetes drug.
- Zepbound fits weight management or sleep apnea without a diabetes-only label, and is the brand Lilly sells self-pay at $299 to $449 [4].
We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money
Online programs that prescribe Zepbound (clean, provisional)
- Clean
- Price
- Zepbound KwikPen $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) a month; Wegovy pill $149 to $299; Wegovy pen $199 for the first 2 months at 0.25 to 0.5 mg, then $349, or $399 for 7.2 mg. Membership $39 the first month, then $74 to $149 a month. Checked Oct 17, 2026 [16].
- What you get
- FDA-approved brand drugs only (Zepbound, Wegovy pen and pill, Foundayo, Ozempic). Helps with insurance prior authorizations.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Membership is billed on top of the drug. The $74 rate needs a 12-month prepay. Verdict: clean (provisional). Ro review
- Clean
- Price
- Wegovy pill from $149, Wegovy pen from $199, Zepbound vial from $299 a month, plus a program fee of $39 the first month and $149 a month after. Checked Oct 17, 2026 [17].
- What you get
- Brand GLP-1s with insurance help. Says compounded drugs "may" be prescribed through a compounding partner, with no products or prices shown.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Its own pages list two different program fees ($149 and $75). Medicare patients are not eligible for the program. Verdict: clean (provisional). LifeMD review
- Price
- Membership $19.99 a month (first month free) plus $129 for the first visit without insurance; medication and labs extra. Checked Oct 17, 2026 [18].
- What you get
- Brand weight-loss prescriptions sent to your own pharmacy; no compounded drugs.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Cheap visits, but you still pay the drug price at your pharmacy or through LillyDirect or NovoCare. Verdict: clean (provisional). PlushCare review
Shared warnings
Both carry a boxed warning for thyroid C-cell tumors in rats and should not be used with a personal or family history of medullary thyroid carcinoma or MEN 2 [9]. Low blood sugar is more common with insulin or a sulfonylurea; on Mounjaro with a sulfonylurea, 9.9% to 13.8% had levels below 54 mg/dL [2]. Get care for severe, lasting stomach pain or signs of an allergic reaction [9]. Call 911 in an emergency.
Background on the drug itself: tirzepatide, Mounjaro and Zepbound.
Questions people ask
Is Mounjaro the same as Zepbound?
Is tirzepatide the same as Zepbound?
Is Zepbound better than Mounjaro for weight loss?
Which is cheaper, Mounjaro or Zepbound?
What is the difference between Zepbound and compounded tirzepatide?
Can you take Mounjaro and Zepbound together?
No. Zepbound should not be used with other tirzepatide-containing products such as Mounjaro [5].
Sources
18 cited
- Zepbound (tirzepatide) prescribing information. DailyMed, NLM/NIH, Aug 2026.
- Mounjaro (tirzepatide) prescribing information. DailyMed, NLM/NIH, Aug 2026.
- Mounjaro FAQ. Eli Lilly and Company, Oct 17, 2026.
- Zepbound on LillyDirect: self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Zepbound FAQ. Eli Lilly and Company, Oct 17, 2026.
- Drug Trials Snapshots: Mounjaro. US Food and Drug Administration, May 13, 2022.
- FDA approves new medication for chronic weight management. US Food and Drug Administration, Nov 8, 2023.
- FDA approves first medication for obstructive sleep apnea. US Food and Drug Administration, Dec 20, 2024.
- Zepbound prescribing information (217806 s050). US Food and Drug Administration, Apr 2026.
- Mounjaro savings resources. Eli Lilly and Company, Oct 17, 2026.
- TrumpRx.gov GLP-1 listings. TrumpRx.gov (US government), Oct 17, 2026.
- Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
- For telehealth companies: what to know when promoting compounded drugs. US Food and Drug Administration, Jun 15, 2026.
- Warning letter: Empower Clinic Services, LLC dba Empower Pharmacy. US Food and Drug Administration, Sep 18, 2026.
- Ro weight loss pricing. Ro, Oct 17, 2026.
- LifeMD weight management. LifeMD, Inc., Oct 17, 2026.
- PlushCare weight loss. PlushCare, Oct 17, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.